Bio-Techne shareholders approve Merck KGaA acquisition
Special meeting clears the $73-per-share, ~$11.3 billion cash deal; HSR waiting period already expired, closing still eyed for late 2026 or early 2027.
Business
Markets, companies, labor, and regulation — event-first coverage of commercial news.
Financials slide as yield curve flattens; 10-year Treasury tops 5%
S&P financials and banks fell Tuesday on AI and curve worries; Wednesday PMI strength pushed the 10-year to its highest since 2007 as stocks slipped again.
Paramount settles with 12 states over Warner Bros. Discovery merger
California-led deal sets film-output floors, $1.5B U.S. production spend, a $47.5M worker fund, and a news independence board; court approval still pending.
U.S. open to extending China trade truce or a broader deal as Xi begins Washington summit
Bessent and He Lifeng met again Wednesday with no agreement announced; Xi arrived at Joint Base Andrews for planned White House events Thursday and Friday.
Federal Reserve holds benchmark rate steady at latest meeting
Policymakers left the federal funds target range unchanged and reiterated a data-dependent approach to future cuts.